News
Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback